Zachary Brennan | in-Pharma Technologist.com | 11-Mar-2014 Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO. Read full article Continue reading
N Sarojini, V Deepa | Indian Journal of Medical Ethics | Vol 10, No 4 | 2013 In mid-2009, the human papillomavirus (HPV) vaccine “demonstration projects” were conducted by the Program for Appropriate Technology in Health (PATH), a Seattle-based non-governmental organisation,… Continue reading
Ravindra B. Ghooi | Perspectives in Clinical Research | V4(4) | 2013 | Source NCBI-PMC Abstract Three amendments to the drugs and cosmetics rules were published in quick succession in 2013. These addressed the issues of compensation of injury and death… Continue reading
Joel Lexchin | Journal of Pharmaceutical Policy and Practice | NCBI | PubMed Central (PMC) | December 2013 Clinical trials present an ethical dilemma for pharmaceutical companies. While companies may want to undertake and report these trials in an ethical… Continue reading
Joel Lexchin | Journal of Pharmaceutical Policy and Pract | 2013 | PubMed Central (PMC) | NCBI | Published online: Dec 2, 2013 Clinical trials present an ethical dilemma for pharmaceutical companies. While companies may want to undertake and report these… Continue reading
Jacob Puliyel | FirstPost | 19 October 2013 On October 11, two children died in Kashmir after receiving the Pentavalent vaccine, taking to six the total deaths there in one week and to eight the deaths over the last three… Continue reading
